ACAD
ACAD
NASDAQ · Biotechnology

Acadia Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$26.40
-0.90 (-3.28%)
As of Sep 21, 8:50 PM ET ·
Analyst Consensus
Strong Buy
27
Analysts
High
Coverage
Buy 21 78%
Hold 5 19%
Sell 1 4%
Price Target
Analyst Price Target -32.2% upside
Low Target $12.70
Average Target $17.90
High Target $23.84
Current Price $26.40
Current
$26.40
Target
$17.90
$12.70 $17.90 avg $23.84
Scenario Analysis
Bear Case
$12.70
-51.9%
Low target
Base Case
$17.90
-32.2%
Avg target
Bull Case
$23.84
+-9.7%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$30.96
-14.7% from high
52-Week Low
$19.69
+34.1% from low
50-Day SMA
$25.91
+1.9% vs SMA
200-Day SMA
$23.44
+12.6% vs SMA
RSI (14)
42.4
Neutral
Target vs 52W High
$17.90
-42.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.7%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -51.4%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +139.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.3%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.3%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -13.8%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -61.5%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -41.0%